Alterations for genes of TP53, MYC, SMARCA4, RB1, ARID1A, and FOXA1, also exhibited significant enrichment in primary tumor specimens from patients who developed BM compared to those who did not have BM. This evidence concerns the gene TP53 and neoplasm.